A modular verification and validation framework for hybrid-capture next-generation sequencing HLA typing in clinical histocompatibility laboratories.
- 1Transplant Biology, Molecular Diagnostics and HSC Manipulation Unit, Azienda USL di Piacenza, Piacenza, Italy.
Abstract
Hybrid-capture next-generation sequencing HLA workflows are increasingly used in clinical histocompatibility laboratories for high-resolution HLA typing. Compared with amplicon-based approaches, they may provide broader coverage of HLA genes, improved ambiguity resolution and the possibility of including additional targets; however, their greater analytical, bioinformatic and interpretative complexity requires a clear definition of intended use, reportable scope and required validation level. A practical and modular framework was developed for the verification and validation of hybrid-capture next-generation sequencing HLA workflows, applicable to IVDR-regulated methods used according to the manufacturer's instructions for use, locally adapted IVDR workflows, research-use-only workflows converted to clinical use, laboratory-developed or laboratory-adapted workflows and outputs not fully covered by manufacturer claims. Core modules required for clinical HLA typing are distinguished from additional modules activated by specific claims or local adaptations, including analytical performance, bioinformatic validation, risk management and reporting governance. It provides an operational pathway to document fitness for intended use and to distinguish clinically reportable results from technically available outputs not validated for diagnostic use. A dataset generated under routine conditions using a commercial full-length HLA capture-based workflow is used as a practical implementation example. A modular structure integrating analytical performance, bioinformatic control, risk-based thinking, reporting governance and continuous monitoring is provided by this framework in clinical immunogenetics and histocompatibility laboratories.
Related
- A Framework for Analytical Validation of Genomic DNA-Based Shotgun Metagenomic Next-Generation Sequencing Workflows
- Case Report: Necrotizing fasciitis caused by Vibrio vulnificus without recalled seafood or seawater exposure diagnosed by metagenomic next-generation sequencing
- Identification of Survival-Associated miRNA Signatures in Glioblastoma Using Next-Generation Sequencing
- Syphilitic bicuspid aortic valve endocarditis diagnosed by metagenomic next-generation sequencing: a case report and literature review
- Cavitary lung squamous cell carcinoma misdiagnosed as pulmonary aspergillosis following targeted next-generation sequencing : A case report
BibTeX
@article{scarpa2026modular,
title = {{A modular verification and validation framework for hybrid-capture next-generation sequencing HLA typing in clinical histocompatibility laboratories.}},
author = {Alice Scarpa and Diego Ferrarese and Samantha Guidotti and Veronica Scaglia and Angela Rossi},
journal = {Frontiers in genetics},
year = {2026},
month = oct,
doi = {10.3389/fgene.2026.1959391},
url = {https://europepmc.org/article/MED/42928830},
note = {CC BY},
}
RIS
TY - JOUR
TI - A modular verification and validation framework for hybrid-capture next-generation sequencing HLA typing in clinical histocompatibility laboratories.
AU - Alice Scarpa
AU - Diego Ferrarese
AU - Samantha Guidotti
AU - Veronica Scaglia
AU - Angela Rossi
PY - 2026
DA - 2026/10/12
JO - Frontiers in genetics
DO - 10.3389/fgene.2026.1959391
UR - https://europepmc.org/article/MED/42928830
AB - Hybrid-capture next-generation sequencing HLA workflows are increasingly used in clinical histocompatibility laboratories for high-resolution HLA typing. Compared with amplicon-based approaches, they may provide broader coverage of HLA genes, improved ambiguity resolution and the possibility of including additional targets; however, their greater analytical, bioinformatic and interpretative complexity requires a clear definition of intended use, reportable scope and required validation level. A practical and modular framework was developed for the verification and validation of hybrid-capture next-generation sequencing HLA workflows, applicable to IVDR-regulated methods used according to the manufacturer's instructions for use, locally adapted IVDR workflows, research-use-only workflows converted to clinical use, laboratory-developed or laboratory-adapted workflows and outputs not fully covered by manufacturer claims. Core modules required for clinical HLA typing are distinguished from additional modules activated by specific claims or local adaptations, including analytical performance, bioinformatic validation, risk management and reporting governance. It provides an operational pathway to document fitness for intended use and to distinguish clinically reportable results from technically available outputs not validated for diagnostic use. A dataset generated under routine conditions using a commercial full-length HLA capture-based workflow is used as a practical implementation example. A modular structure integrating analytical performance, bioinformatic control, risk-based thinking, reporting governance and continuous monitoring is provided by this framework in clinical immunogenetics and histocompatibility laboratories.
SN - 1664-8021
ER -